Estrogen & Blood Clots: Do You Need to Worry that Your HRT Will Kill You? | Felice Gersh, MD

Why It Matters

Understanding estrogen’s nuanced effects prevents unnecessary fear and guides safer HRT choices, reducing clot‑related morbidity for millions of women.

Key Takeaways

• Different estrogen types have distinct effects on clotting risk.
• Transdermal estradiol does not increase blood clot risk.
• Oral estrogen converts to estrone, promoting inflammation and clotting.
• Estradiol modulates immune response, acting as on/off switch.
• Genetic factors like Factor V Leiden amplify estrogen‑related clot risk.

Summary

The video tackles the common belief that estrogen inevitably causes dangerous blood clots, distinguishing between estrogen sub‑types and delivery methods. Dr. Gersh explains that estrogen is a family of hormones—estrone (E1), estradiol (E2), and estriol (E3)—each interacting differently with the immune system and platelet activity.

Key insights include how estradiol, the hormone used in transdermal hormone‑replacement therapy, does not trigger inappropriate platelet aggregation. In contrast, oral estrogen passes through the liver, converting largely to estrone, which acts as an “on‑switch” for inflammation and raises clotting factor production. This metabolic pathway, combined with age‑related chronic inflammation, explains why oral formulations raise clot risk.

Notable examples: oral estradiol doubles clot risk, conjugated equine estrogens quadruple it, and the risk spikes sixteen‑fold in women homozygous for Factor V Leiden. Dr. Gersh emphasizes that a transdermal estradiol patch shows no increase in clot incidence, underscoring the importance of formulation.

Implications for clinicians and patients are clear: prioritize transdermal estradiol for hormone therapy, screen for genetic clotting disorders, and educate that not all estrogen therapies carry equal danger. Proper choice mitigates risk while preserving the benefits of hormone replacement.

Original Description

The critical info: Oral estrogen increases clot risk. Transdermal estradiol does not

In this talk, I explain why the statement “estrogen causes blood clots” is an oversimplification. Estrogen is a family of hormones, and different forms behave very differently in the body.

I review how blood clots form, why oral estrogen increases clotting risk through liver effects, and why transdermal estradiol acts differently by helping regulate inflammation and platelet activity.

Watch for my latest Instagram lives at

https://www.instagram.com/dr.felicegersh

I am a full time practicing doctor. I see patients in my office in Irvine, CA and worldwide via telemedicine. If you need more healthcare assistance than I can provide in a video series, please contact my office:

https://integrativemgi.com/​​

#MenopauseHealth #Perimenopause #HormoneTherapy #MHT

#MenopauseHealth #BloodClots #WomensHealth #Estradiol #HRT #HormoneHealth #HealthyAging #IntegrativeMedicine #healthyaging #DrFeliceGersh

----- Contents of this video ---------------------------

00:00 does estrogen cause blood clots

01:00 estrogen is a family of hormones, not one hormone

02:30 what causes blood clots in the body

04:30 platelets and why clotting can be life-saving

08:30 inflammation, aging, and clot risk

10:00 how estradiol regulates the immune system

12:00 what happens when you take oral estrogen

14:30 estrone, inflammation, and clotting risk

17:00 birth control, oral estrogen, and increased clot risk

20:00 why transdermal estradiol does not increase clot risk

23:00 other real causes of blood clots beyond hormones